Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine in elderly patients with dysthymic disorder
NCT01852383Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Jan 2006
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of duloxetine in persistent depressive disorder (PDD), sponsored by New York State Psychiatric Institute. Primary endpoint: Hamilton Rating Scale for Depression at 12 weeks. Started Jan 2006; status: completed.
02
Drugs
duloxetine
03
Conditions
persistent depressive disorder (PDD)
Beyond the preview
Go deeper on NCT01852383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01852383.